As the first production units of an innovative solvent removal system are shipped to both sides of the Atlantic, orders above predicted levels are reported
Following its recent launch at major US and European exhibitions, Genevac reports huge interest in its innovative EZ-2 personal evaporator.
Buoyed by orders above predicted levels, Genevac will deliver the first EZ-2 production units to clients on both sides of the Atlantic.
RiboTargets, the UK drug discovery company will be the first European user of the revolutionary new system, while in the USA, the Virginia Polytechnic Institute will take delivery of the first unit to go Stateside this summer.
The EZ-2 features state-of-the-art software to cope with the solvent removal needs of most chemists working with parallel synthesis and medicinal chemistry.
The 'auto stop when dry' feature is seen as a particularly useful benefit as solvent removal tasks can be left to run unattended in safety, allowing chemists to pursue more productive work.
RiboTargets will use the EZ-2 to free-up time on its existing Genevac high throughput solvent removal platform, the HT-8.
The majority of its work is carried out in microtitre plates, although the EZ-2 and HT-8 can take tubes, vials and flasks with equal results.
The Virginia Tech unit will be used for drying-down HPLC fractions from a gradient fraction collector where simplicity, ease of use, and an ability to cope with small imbalances are all important.
